Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Optical Microangiography and Progressive Retinal Nerve Fiber Layer Loss in Primary Open Angle Glaucoma

PURPOSE To evaluate the association between optical microangiography (OMAG) measurements and progressive retinal nerve fiber layer (RNFL) loss in primary open angle glaucoma (POAG). DESIGN Prospective case series. METHODS Sixty-four…

read more

Long-Term Outcomes and Risk Factors for Severe Vision Loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV)

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Long-Term Outcomes and Risk Factors for Severe Vision Loss in Autosomal Dominant Neovascular Inflammatory Vitreoretinopathy (ADNIV)

Purpose Autosomal dominant neovascular inflammatory vitreoretinopathy (ADNIV) is a rare disorder characterized by uveitis, retinal neovascularization, and retinal degeneration. We sought to describe the course of treated and untreated ADNIV…

read more

Timing of Ocular Hypertension After Pediatric Closed-Globe Traumatic Hyphema: Implications for Surveillance

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Timing of Ocular Hypertension After Pediatric Closed-Globe Traumatic Hyphema: Implications for Surveillance

Highlights • Traumatic hyphema with closed-globe injury leads to ocular hypertension often (40%). • Ocular hypertension occurs over a broad time frame after hyphema. • Long-term surveillance for ocular hypertension…

read more

Can Artificial Intelligence Predict Glaucomatous Visual Field Progression? A Spatial–Ordinal Convolutional Neural Network Model

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Can Artificial Intelligence Predict Glaucomatous Visual Field Progression? A Spatial–Ordinal Convolutional Neural Network Model

Purpose: To develop an artificial neural network model incorporating both spatial and ordinal approaches to predict glaucomatous visual field (VF) progression. Design: Cohort study. Methods From a cohort of primary…

read more

Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Half-Dose Photodynamic Therapy Versus Eplerenone in Chronic Central Serous Chorioretinopathy (SPECTRA): A Randomized Controlled Trial

Purpose To compare the efficacy and safety between half-dose photodynamic therapy (PDT) and eplerenone therapy for treating chronic central serous chorioretinopathy (cCSC). Design This was a multicenter, open-label, randomized controlled…

read more

Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16

Jan 3, 2022 by in OPHTHALMOLOGY Comments Off on Longitudinal Changes of Fixation Stability and Location Within 24 Months in Stargardt Disease: ProgStar Report No. 16

Purpose Stargardt disease type 1 (STGD1) is the most common macular dystrophy. The assessment of fixation describes an important dimension of visual function, but data on its progression over time…

read more
Get Clinical Tree app for offline access